Guardion Health Sciences, Inc. (GHSI)
USD 3.22
(0.0%)
USD 3.22
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.91 Million USD | -45.04% |
| 2022 | 21.68 Million USD | -7.56% |
| 2021 | 23.46 Million USD | 137.92% |
| 2020 | 9.86 Million USD | -23.42% |
| 2019 | 12.87 Million USD | 249.81% |
| 2018 | 3.68 Million USD | -50.05% |
| 2017 | 7.37 Million USD | 2712.58% |
| 2016 | 262.04 Thousand USD | 6.62% |
| 2015 | 245.76 Thousand USD | -10.26% |
| 2014 | 273.87 Thousand USD | -40.8% |
| 2013 | 462.64 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 10.4 Million USD | -12.68% |
| 2024 Q2 | 15.29 Million USD | 47.01% |
| 2023 Q4 | 11.91 Million USD | -7.45% |
| 2023 Q2 | 13.47 Million USD | -6.55% |
| 2023 FY | 11.91 Million USD | -45.04% |
| 2023 Q3 | 12.87 Million USD | -4.43% |
| 2023 Q1 | 14.41 Million USD | -33.51% |
| 2022 Q2 | 29.83 Million USD | -5.65% |
| 2022 Q1 | 31.62 Million USD | 34.78% |
| 2022 FY | 21.68 Million USD | -7.56% |
| 2022 Q4 | 21.68 Million USD | -23.18% |
| 2022 Q3 | 28.22 Million USD | -5.38% |
| 2021 Q2 | 41.28 Million USD | -7.65% |
| 2021 Q3 | 38.61 Million USD | -6.47% |
| 2021 Q4 | 23.46 Million USD | -39.24% |
| 2021 Q1 | 44.7 Million USD | 353.33% |
| 2021 FY | 23.46 Million USD | 137.92% |
| 2020 Q2 | 14.03 Million USD | -8.17% |
| 2020 Q3 | 12.15 Million USD | -13.36% |
| 2020 Q4 | 9.86 Million USD | -18.9% |
| 2020 Q1 | 15.28 Million USD | 18.69% |
| 2020 FY | 9.86 Million USD | -23.42% |
| 2019 Q3 | 8.95 Million USD | 57.16% |
| 2019 FY | 12.87 Million USD | 249.81% |
| 2019 Q4 | 12.87 Million USD | 43.79% |
| 2019 Q2 | 5.69 Million USD | 43.5% |
| 2019 Q1 | 3.97 Million USD | 7.87% |
| 2018 Q3 | 3.88 Million USD | -20.12% |
| 2018 Q4 | 3.68 Million USD | -5.27% |
| 2018 FY | 3.68 Million USD | -50.05% |
| 2018 Q1 | 5.91 Million USD | -19.73% |
| 2018 Q2 | 4.86 Million USD | -17.77% |
| 2017 Q2 | 512.73 Thousand USD | -20.32% |
| 2017 Q1 | 643.46 Thousand USD | 145.55% |
| 2017 FY | 7.37 Million USD | 2712.58% |
| 2017 Q4 | 7.37 Million USD | 90.04% |
| 2017 Q3 | 3.87 Million USD | 656.4% |
| 2016 Q1 | - USD | -100.0% |
| 2016 FY | 262.04 Thousand USD | 6.62% |
| 2016 Q4 | 262.04 Thousand USD | -56.35% |
| 2016 Q3 | 600.33 Thousand USD | 25.74% |
| 2016 Q2 | 477.42 Thousand USD | 0.0% |
| 2015 Q1 | -1.81 Million USD | -761.84% |
| 2015 Q4 | 245.76 Thousand USD | -15.51% |
| 2015 Q3 | 290.88 Thousand USD | 0.0% |
| 2015 FY | 245.76 Thousand USD | -10.26% |
| 2014 FY | 273.87 Thousand USD | -40.8% |
| 2014 Q4 | 273.87 Thousand USD | 0.0% |
| 2013 FY | 462.64 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bright Green Corporation | 17.4 Million USD | 31.517% |
| BioQuest Corp. | 5914.00 USD | -201424.806% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | 61.853% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 97.066% |
| GSRX Industries Inc. | - USD | -Infinity% |
| High Sierra Technologies, Inc. | 101.5 Thousand USD | -11641.815% |
| Instadose Pharma Corp. | - USD | -Infinity% |